RVL Pharmaceuticals plc (RVLP) reported Q2 EPS of ($0.14), $0.10 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $8.4 million versus the consensus estimate of $8.72 million.
RVL Pharmaceuticals plc (RVLP) reported Q2 EPS of ($0.14), $0.10 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $8.4 million versus the consensus estimate of $8.72 million.